Earnings Call Insights: GoodRx (GDRX) Q1 2026 Management View CEO Wendy Barnes said the quarter showed “continued momentum across our strategic growth priorities,” citing “strength in revenue, disciplined execution on profitability, and healthy engagement across the platform,” and adding that “the strategy we laid out last quarter is working.” Barnes positioned the company around manufacturer and ...
Earnings Call Insights: GoodRx (GDRX) Q1 2026 Management View CEO Wendy Barnes said the quarter showed “continued momentum across our strategic growth priorities,” citing “strength in revenue, disciplined execution on profitability, and healthy engagement across the platform,” and adding that “the strategy we laid out last quarter is working.” Barnes positioned the company around manufacturer and GLP-1 demand, saying “GoodRx Pharma Direct continues to be a key growth engine,” with “82% growth year-over-year,” and noting “we now have more than 125 self-pay programs live.” She added that a third-party source indicated GoodRx “accounted for approximately 1/3 of all Wegovy Pill transactions in the first 2 months post-launch.” Barnes highlighted new manufacturer activity and distribution, saying the company “announced a collaboration with Viatris to support savings availability for 17 of its established brand medications” and “introduced significant discounts from Pfizer on more than 30 of its essential medications… made available through a dedicated Pfizer-branded storefront on GoodRx and on TrumpRx as part of our integration.” CFO Christopher McGinnis reported profitability and the revenue mix shift: “For the first quarter, we delivered revenue of $194 million and adjusted EBITDA of $58.3 million, representing an adjusted EBITDA margin of 30%.” Outlook McGinnis raised full-year guidance: “For the full year 2026, we are raising our guidance and now expect revenue to be in the range of $765 million to $785 million and adjusted EBITDA to be at least $235 million.” Management reiterated continued pressure in the legacy marketplace economics: “While we expect continued pressure on prescription transactions revenue in 2026, our increase in guidance is driven primarily by stronger-than-expected performance in Pharma Direct.” McGinnis updated the segment growth expectation: “Consequently, we now expect Pharma Direct revenue to grow over 50% year-over-year,” and added that “sub...
(RTTNews) - COWAY (021240.KS) reported first quarter net income attributable to shareholders of the parent company of 182.0 billion Korean won, a 31.0% increase from the prior year period. Operating income was 250.9 billion won, up 18.8% year-over-year from 211.2 billion won, las
(RTTNews) - COWAY (021240.KS) reported first quarter net income attributable to shareholders of the parent company of 182.0 billion Korean won, a 31.0% increase from the prior year period. Operating income was 250.9 billion won, up 18.8% year-over-year from 211.2 billion won, las
Michael Derrer Fuchs/iStock Editorial via Getty Images Sony Group ( SONY ) said Friday it plans to repurchase up to ¥500B ($3.2B) worth of shares as it issued a profit outlook that was broadly in line with expectations. More on Sony Sony Group: A Wide Moat Compounder At A 15x P/E Gift (Rating Upgrade) Sony closes in on a music rights deal covering Shakira, Journey, Neil Young, Justin Bieber, and m...
Michael Derrer Fuchs/iStock Editorial via Getty Images Sony Group ( SONY ) said Friday it plans to repurchase up to ¥500B ($3.2B) worth of shares as it issued a profit outlook that was broadly in line with expectations. More on Sony Sony Group: A Wide Moat Compounder At A 15x P/E Gift (Rating Upgrade) Sony closes in on a music rights deal covering Shakira, Journey, Neil Young, Justin Bieber, and more Sony Financial shares fall as Sony Life probes dozens of alleged customer misconduct cases Seeking Alpha’s Quant Rating on Sony Historical earnings data for Sony
Earnings Call Insights: Open Lending (LPRO) Q1 2026 Management View Chairman & CEO Jessica Buss framed Q1 as execution on a deliberate risk pullback, saying, "The first quarter marked another step forward in our operational execution and reinforce the impact of the changes we've been making across the organization." She added, "The macroeconomic environment remains challenging. Credit quality pres...
Earnings Call Insights: Open Lending (LPRO) Q1 2026 Management View Chairman & CEO Jessica Buss framed Q1 as execution on a deliberate risk pullback, saying, "The first quarter marked another step forward in our operational execution and reinforce the impact of the changes we've been making across the organization." She added, "The macroeconomic environment remains challenging. Credit quality pressures and consumer stress continue to weigh on the auto lending market." Buss highlighted top-of-funnel growth with tighter approvals, stating, "While applications grew 18% year-over-year, driven by stronger go-to-market performance, approval rates declined as a direct result of our deliberate decision to pull back from higher risk credit segments and borrowers in favor of higher quality certified loan volume." She emphasized, "Quality continues to take precedence over quantity." Buss reported Q1 certified loan volume and reiterated the full-year target, saying, "We facilitated 21,064 certified loans in the first quarter," and added that volume "exceeded the top end of our guidance" while the company believes it is positioned "to achieve full year guidance of 100,000 to 110,000 certified loans." Buss detailed channel mix and growth drivers, including that results were driven by "slightly stronger-than-expected volume in our core credit union channel and the continued ramp of OEM 3," while "legacy OEM certs continue their intentional decline." She said the OEM 3 rollout is expected to be back-half weighted: "the most meaningful cert contribution expected to come in the third and fourth quarters." On underwriting and unit economics, Buss said, "Based on the underwriting changes and rate increases we took in 2025 and resulting book mix, we have booked our Q1 2026 vintage certs at a 70% loss ratio versus the 72.5% we used for the full year 2025," adding, "At a 70% loss ratio, we are still maintaining the same level of constrained conservatism at the time of origination." CFO Ma...
Amneal Pharmaceuticals press release ( AMRX ): Q1 Non-GAAP EPS of $0.27 beats by $0.10 . Revenue of $722.52M (+3.9% Y/Y) beats by $5.74M . Adjusted EBITDA in the first quarter of 2026 was $202 million, an increase of 19% compared to the first quarter of 2025, reflecting higher revenue and gross profit. Affirms Previously Announced Increase in 2026 Full Year Guidance Affirming Previously Announced ...
Amneal Pharmaceuticals press release ( AMRX ): Q1 Non-GAAP EPS of $0.27 beats by $0.10 . Revenue of $722.52M (+3.9% Y/Y) beats by $5.74M . Adjusted EBITDA in the first quarter of 2026 was $202 million, an increase of 19% compared to the first quarter of 2025, reflecting higher revenue and gross profit. Affirms Previously Announced Increase in 2026 Full Year Guidance Affirming Previously Announced (on April 22, 2026) Increased 2026 Full Year Guidance Net revenue $3.05 billion - $3.15 billion vs. consensus of $3.10B Adjusted EBITDA (1) $740 million - $770 million Adjusted diluted EPS (2) $0.95 - $1.05 vs. consensus of $1.00 Operating cash flow (3) $350 million - $400 million Operating cash flow, excluding discrete items (4) $375 million - $425 million Capital expenditures (5) ~$110 million Click to enlarge More on Amneal Pharmaceuticals Amneal Pharmaceuticals, Inc. 2026 Q1 - Results - Earnings Call Presentation Amneal Pharmaceuticals, Inc. (AMRX) Q1 2026 Earnings Call Transcript Amneal: A Robust Drug Portfolio Worth Watching, Driving Further Upside Potential Amneal Pharmaceuticals Q1 2026 Earnings Preview Amneal anticipates deleveraging below 3x by 2028 as it outlines $4.3B-$4.5B 2030 revenue target following Kashiv deal
Shares of leading diagnostics platform and cancer-detecting genomic test provider Veracyte (NASDAQ: VCYT) are up 23% over the last week as of market close Thursday, after the company reported excellent first-quarter earnings earlier in the week. Veracyte's sales grew by 21%, and its earnings per share quadrupled, as its net income margin improved from 6% to 21% year over year. Both of these figure...
Shares of leading diagnostics platform and cancer-detecting genomic test provider Veracyte (NASDAQ: VCYT) are up 23% over the last week as of market close Thursday, after the company reported excellent first-quarter earnings earlier in the week. Veracyte's sales grew by 21%, and its earnings per share quadrupled, as its net income margin improved from 6% to 21% year over year. Both of these figures soared past Wall Street's estimates. Management guided for sales growth between 13% and 14% in 2026, with margins remaining robust. It was an all-around great quarter for Veracyte, as the company announced: Image source: Getty Images. Continue reading
gentlelight/iStock via Getty Images Teradyne ( TER ) is a technology company best known for making automated testing equipment used in the semiconductor industry. They build systems that chipmakers use to test whether advanced chips actually work before they get shipped into products like AI servers, smartphones, cars, and networking equipment. Outside of semiconductor testing, they also have busi...
gentlelight/iStock via Getty Images Teradyne ( TER ) is a technology company best known for making automated testing equipment used in the semiconductor industry. They build systems that chipmakers use to test whether advanced chips actually work before they get shipped into products like AI servers, smartphones, cars, and networking equipment. Outside of semiconductor testing, they also have business segments in product testing and robotics. Their core business is Automated Test Equipment (ATE). Their systems electrically test semiconductors during manufacturing to detect defects, performance issues, and reliability problems. They run testing on CPUs, GPUs, AI accelerators, and various chips, like smartphone, automotive, and memory. Seeking Alpha After being essentially flat over almost half a decade, the stock has been a home run the last year and is up over 400%. Outside of the expected rise in valuation, I can’t find much I don’t like with TER, and I have the stock as a buy. They just reported record Q1 earnings and financials on many accounts. Guidance for the remainder of 2026 is a bit mellow, but long-term plans and forecasting are strong. They are well a part of the AI infrastructure boom and have solidified themselves in a position to capture huge market share for a long time to come. Best Quarter Yet TER TER just reported a record in both earnings and revenue for Q1 2026, with both results being well above the indicated guidance. Adjusted EPS was $2.56, blowing out any quarter they’ve ever had, and revenue was $1.28 billion, up 87% YoY. CEO Greg Smith notes that about 70% of revenue was from AI-related demand, and each of their three business segments saw growth as the AI momentum is a major catalyst. Operating profit skyrocketed, gaining almost 4x YoY, reaching $473 million for the quarter. Gross margin helped drive the charge and was 60.9% in Q1. This is slightly above where they typically are on margin, but I think this could be the new reality if the A...
Hi, this is Allen Wan in Shanghai, where a group of US senators kicked off a visit to China this week. Such events are typically a diplomatic nicety aimed at drumming up business for the states the lawmakers represent. But this one took on added importance because it comes ahead of Donald Trump’s highly anticipated summit with Xi Jinping in Beijing next week — the first by a US leader since 2017. ...
Hi, this is Allen Wan in Shanghai, where a group of US senators kicked off a visit to China this week. Such events are typically a diplomatic nicety aimed at drumming up business for the states the lawmakers represent. But this one took on added importance because it comes ahead of Donald Trump’s highly anticipated summit with Xi Jinping in Beijing next week — the first by a US leader since 2017. During his meeting with Shanghai Mayor Gong Zheng at an Art Deco hotel in a swanky part of the financial hub, Trump ally Steve Daines said he was “pleased to see that things have somewhat deescalated” in recent months. The better vibes between China and the US that the Republican from Montana highlighted remain in place despite moves by both sides that in the past may have sparked a diplomatic tempest. For example, Trump has been trying to rebuild the tariff wall struck down by US courts; aiming to curb Chinese influence in the Western Hemisphere ; and launching attacks against Iran and Venezuela, two of Beijing’s friends and sources of cheap oil for its export-reliant economy. China has held its own in this regard since Xi and Trump negotiated a one-year trade truce in South Korea last fall. Beijing has maintained tight control of its exports of the rare earths vitally important to the US economy , tried to undercut the dollar’s dominance by promoting trade in the yuan and made it hard for Nvidia to sell its advanced chips in the country. It sought to unwind Meta’s purchase of the Chinese startup Manus , a deal that could extend America’s lead in AI. And has directed companies not to abide by US sanctions on private refiners linked to the Iranian oil trade, though it has also advised the largest banks to temporarily suspend new loans to five plants . Oh, and the Taiwan question remains a lingering worry for both sides. Illustrating how the issue remains front of mind, this week Secretary of State Marco Rubio said neither nation wants it to destabilize Asia . Then there is ...
New Zealand’s government is reiterating it wants state-owned Kiwibank to become a stronger competitor and that it should be open to raising capital to fund growth, including via a partial share sale. In a letter to parent company Kiwi Group Capital released Friday, the government urged it and Kiwibank to consider how it could significantly increase its relative growth. “We expect KGC to undertake ...
New Zealand’s government is reiterating it wants state-owned Kiwibank to become a stronger competitor and that it should be open to raising capital to fund growth, including via a partial share sale. In a letter to parent company Kiwi Group Capital released Friday, the government urged it and Kiwibank to consider how it could significantly increase its relative growth. “We expect KGC to undertake work on alternative growth scenarios for Kiwibank along with the capital required for these,” State-owned Enterprises Minister Simeon Brown said in the letter dated late March. “We also expect you to engage with the Treasury on these scenarios, and the implications they would have for the Crown.” Last year, the government cleared Kiwi Group to raise as much as NZ$500 million ($297 million) of extra capital to fund growth, arguing the bank could become a disruptive competitor to the four Australian-owned lenders that dominate the market. However, after the Reserve Bank adjusted its bank capital requirements in December, Kiwibank said it no longer needed the extra capital. Read more: New Zealand Targets Australian Banks With Kiwibank Capital Boost The government also said at the time it was prepared to consider allowing the group to access new capital through a public share offering, but said that would require an electoral mandate. Brown repeated that message in his letter. In a February cabinet paper also released Friday, officials said Kiwibank can grow in-line with its current business plan over the next several years without additional capital. “However, KGC and Kiwibank should plan for what is needed to accelerate towards its full potential as a market disruptor,” the paper said. “This involves developing business strategies for accelerating lending growth, determining the timing and amount of capital needed to support that growth, and framing its sourcing.” Officials said the Crown could continue to be the sole provider, or be one of the contributors, of additional cap...
ilkercelik/E+ via Getty Images Key Takeaways • Markets: The first quarter of 2026 was characterized by elevated geopolitical risk and accelerating AI-driven disruption across the software sector and its incumbent business models. The period was shaped by a series of international developments, including the capture and indictment of Nicolás Maduro, escalating diplomatic tensions between the US and...
ilkercelik/E+ via Getty Images Key Takeaways • Markets: The first quarter of 2026 was characterized by elevated geopolitical risk and accelerating AI-driven disruption across the software sector and its incumbent business models. The period was shaped by a series of international developments, including the capture and indictment of Nicolás Maduro, escalating diplomatic tensions between the US and European NATO allies over Greenland, and a US-Israeli military operation against Iran. • Contributors: Duration positioning was beneficial to performance. • Detractors: Yield-curve positioning was a slight detractor from performance. • Outlook: Geopolitical tensions remain a defining feature of the outlook, with the Middle East conflict introducing ongoing uncertainty and contributing to oil price volatility as supply routes face occasional disruption. Even with these pressures, the global economic backdrop is gradually improving as fiscal support, easier financial conditions and moderating inflation help strengthen the 2026 outlook. Performance Review • The portfolios outperformed the benchmark (gross of fees and underperformed net of fees). • Tactical duration positioning contributed to performance. • Yield-curve positioning had a small negative impact on returns. • Sector positioning and security selection did not have a meaningful impact on returns. Outlook • In the US, policy tailwinds and deregulation continue to support activity despite signs of softer labor conditions. • Europe and the United Kingdom face trade and labor-market challenges but easing inflation and selective fiscal measures offer stabilization. • China's recovery remains policy-driven amid structural constraints, while Japan's persistent inflation supports further policy normalization. • Credit markets remain supported by strong fundamentals and healthy demand, with issuance elevated by AI-related capex, M&A and refinancing needs. Average annual total returns (%) - as of March 31, 2026-PRELIMINARY Co...
(RTTNews) - MercadoLibre (MELI) reported that its first quarter net income declined to $417 million from $494 million, prior year. Net income available to shareholders per common share was $8.23 compared to $9.74. Adjusted EBITDA declined to $857 million from $935 million.
(RTTNews) - MercadoLibre (MELI) reported that its first quarter net income declined to $417 million from $494 million, prior year. Net income available to shareholders per common share was $8.23 compared to $9.74. Adjusted EBITDA declined to $857 million from $935 million.
Like many AI companies automating work that humans currently do, Basata will eventually face a harder question about where the line is between augmenting workers and displacing them. For now, the founders say the administrative staff they work with aren't worried about that; they're more worried about drowning.
Like many AI companies automating work that humans currently do, Basata will eventually face a harder question about where the line is between augmenting workers and displacing them. For now, the founders say the administrative staff they work with aren't worried about that; they're more worried about drowning.
Earnings Call Insights: LightPath Technologies (LPTH) Q3 fiscal 2026 Management View CEO Sam Rubin said the quarter reflected “continued momentum of strong top line growth,” alongside “continued buildup of our backlog with a strong book-to-bill ratio and improvements in our EBITDA and overall financial performance.” Rubin framed LightPath’s strategy as a multi-year transformation: “The LightPath o...
Earnings Call Insights: LightPath Technologies (LPTH) Q3 fiscal 2026 Management View CEO Sam Rubin said the quarter reflected “continued momentum of strong top line growth,” alongside “continued buildup of our backlog with a strong book-to-bill ratio and improvements in our EBITDA and overall financial performance.” Rubin framed LightPath’s strategy as a multi-year transformation: “The LightPath of today looks very little like the component supplier we were a few years ago. We now cover the full stack, proprietary materials, optical assemblies and complete imaging systems.” Rubin positioned BlackDiamond (chalcogenide glass) around defense supply-chain requirements, saying the NDAA “requires U.S. defense programs to move off of glass and optical components sourced from China, Russia and other covered nations no later than January 1, 2030,” and added that LightPath is “well ahead of the rest of the market.” Rubin said G5 Infrared “has booked more than $100 million of new orders” over the last year and described demand signals for redesigned cameras using BlackDiamond: “even before we have completed those redesigns, we already saw an influx of orders for those redesigned cameras.” On the Amorphous Materials acquisition, Rubin said it expands BlackDiamond optic diameter capability from “up to 5 inches” to “up to as much as 10 inches,” and that adding Amorphous “pretty much doubled our glass capacity, and it is nowhere near enough.” Rubin highlighted demand concentration in higher-value products: “the cameras and assemblies business… represent 44% of the revenue… [and] more than $75 million of our backlog.” Rubin announced leadership additions: “Doug Schoen joined us as Senior Vice President of Global Sales; and Ryan Workman joined us as Vice President of Business Development and Product Management.” CFO Albert Miranda reported, “Revenue for the third quarter of fiscal 2026 increased 109% to $19.1 million,” and gross profit rose to “$7 million, or 36% of total revenues.”...
Baidu Inc. ’s chip unit Kunlunxin is planning an initial public offering on Shanghai’s Nasdaq-style bourse in addition to a separate listing plan in Hong Kong as the Chinese search engine giant looks to taps investor appetite for semiconductor stocks. The chipmaking unit is seeking an IPO on Shanghai’s STAR Board and is working with China International Capital Corp., according to a statement filed...
Baidu Inc. ’s chip unit Kunlunxin is planning an initial public offering on Shanghai’s Nasdaq-style bourse in addition to a separate listing plan in Hong Kong as the Chinese search engine giant looks to taps investor appetite for semiconductor stocks. The chipmaking unit is seeking an IPO on Shanghai’s STAR Board and is working with China International Capital Corp., according to a statement filed by the investment bank to the Chinese Securities Regulatory Commission. Earlier this year, Baidu said Kunlunxin had confidentially filed for an offering in Hong Kong. Baidu’s stock in Hong Kong jumped as much as 4.1% on Friday. Investor interests in China’s homegrown chipmakers is unabated . The shares of companies including Shanghai Biren Technology Co., Metax Integrated Circuits Shanghai Co. and Moore Threads Technology Co. have surged since debuts last year. Kunlunxin, which Baidu holds a 58% stake in, is valued at at least $3 billion , Bloomberg reported in December. Shanghai’s tech-heavy Star 50 Index has surged more than 20% this year and reached an all-time high on Thursday. Pursing a listing in Shanghai shows progress in Baidu’s plan to carve out Kunlunxin as the onshore listing makes it easier for Chinese AI model developers and chipmakers to access to domestic investors, Jefferies analysts including Thomas Chong said in a note on Friday. It expects Kunlunxin’s Hong Kong listing to happen in the third quarter. Chinese up-and-coming tech companies, including chipmakers and firms across the AI ecosystem, have brought a wave of IPOs to the market both in Hong Kong and onshore over the past year. Their fundraising is part of Beijing’s efforts to nurture local semiconductor champions in the face of US restrictions over advanced chips made by the likes of Nvidia Corp. Baidu’s rival Alibaba is also said to plan a listing of its chipmaking arm . Baidu started the chipmaking business years ago to provide computing power for its AI ambitions. It said earlier this year that ...
Scorpio Tankers ( STNG ) has priced a private offering of $200M aggregate principal amount of additional 1.75% convertible senior notes due 2031. The offering size was increased from the previously announced $150M aggregate principal amount of new notes, which were priced at 110.25% of par, plus approximately $1.56 in accrued interest per $1,000 principal amount from April 10, 2026, through May 11...
Scorpio Tankers ( STNG ) has priced a private offering of $200M aggregate principal amount of additional 1.75% convertible senior notes due 2031. The offering size was increased from the previously announced $150M aggregate principal amount of new notes, which were priced at 110.25% of par, plus approximately $1.56 in accrued interest per $1,000 principal amount from April 10, 2026, through May 11, 2026, with additional accrued interest payable if settlement occurs after May 12, 2026. The company also agreed to repurchase 649,427 shares concurrently with the offering’s closing in privately negotiated transactions at $84.69 per share. The offering is expected to close on May 12, 2026. More on Scorpio Tankers Scorpio Tankers Inc. (STNG) Q1 2026 Earnings Call Transcript Scorpio Tankers Inc. 2026 Q1 - Results - Earnings Call Presentation Scorpio Tankers - Looking Closer At 2026E Oil Transportation Scorpio Tankers raised to Buy at BofA with rates seen staying elevated Scorpio Tankers expects ~3% fleet growth over next 3 years as it authorizes $500M buyback